10-KPeriod: FY2024

TEXAS INSTRUMENTS INC Annual Report, Year Ended Dec 31, 2024

Filed February 14, 2025For Securities:TXN

Summary

Texas Instruments Inc. (TXN) reported fiscal year 2024 revenue of $15.64 billion, a decrease of 10.7% from the prior year, primarily driven by lower revenue in its core Analog and Embedded Processing segments. Despite the revenue decline, the company emphasizes its strategy centered on maximizing long-term free cash flow per share, supported by four competitive advantages: manufacturing/technology, broad product portfolio, market channel reach, and product/market diversity. Significant investments are being made in expanding 300mm manufacturing capacity in Texas and Utah to support future growth and cost efficiencies. The company generated $6.32 billion in cash flow from operations and $1.50 billion in free cash flow, representing 9.6% of revenue, and returned $5.72 billion to shareholders through dividends and share repurchases. The CHIPS and Science Act is expected to provide significant financial benefits, including tax credits and direct funding for new manufacturing facilities. While facing industry cyclicality and competitive pressures, Texas Instruments remains focused on disciplined capital allocation and operational efficiency to drive long-term shareholder value.

Financial Statements
Beta

Key Highlights

  • 1Revenue for 2024 was $15.64 billion, a 10.7% decrease year-over-year, attributed to declines in both Analog and Embedded Processing segments.
  • 2The company's core strategy remains focused on maximizing long-term free cash flow per share growth, leveraging four competitive advantages in manufacturing, product breadth, market channels, and diversity.
  • 3Significant capital expenditures of $4.82 billion were made in 2024, primarily for expanding 300mm wafer fabrication capacity to support future demand and enhance cost advantages.
  • 4Texas Instruments generated $6.32 billion in cash flow from operations and $1.50 billion in free cash flow (9.6% of revenue) in 2024.
  • 5The company returned $5.72 billion to shareholders in 2024 through dividends ($4.80 billion) and share repurchases ($0.93 billion).
  • 6The U.S. CHIPS and Science Act is expected to provide between $7.5 billion to $9.5 billion through 2034, including investment tax credits and direct funding for manufacturing facilities.
  • 7Gross profit margin decreased to 58.1% in 2024 from 62.9% in 2023, largely due to lower revenue and increased manufacturing costs related to capacity expansions.

Frequently Asked Questions

Texas Instruments' primary revenue-generating segments are Analog and Embedded Processing. In 2024, revenue from the Analog segment was $12.16 billion (a 7% decrease year-over-year), and revenue from the Embedded Processing segment was $2.53 billion (a 25% decrease year-over-year). Overall revenue for the company was $15.64 billion, down 10.7% from 2023.

Texas Instruments' core strategy is to maximize long-term free cash flow per share growth. This is achieved through three key elements: maintaining a strong business model built on four competitive advantages (manufacturing/technology, broad product portfolio, market channel reach, and product/market diversity), disciplined capital allocation, and a focus on operational efficiency.

The company is making substantial investments in expanding its 300mm wafer fabrication capacity. Key investments include ramping production at RFAB2 in Texas and LFAB1 in Utah, equipping and constructing SM1 and SM2 in Sherman, Texas, and continuing construction on LFAB2 in Utah. These investments are designed to strengthen its manufacturing and technology competitive advantage, lower costs, enhance supply chain control, and support future revenue growth.

The CHIPS and Science Act is a significant tailwind for Texas Instruments. The company expects to receive between $7.5 billion to $9.5 billion through 2034. This includes a 25% investment tax credit for qualified U.S. manufacturing investments and direct funding of up to $1.6 billion for its new wafer fabrication facilities in Sherman, Texas, and Lehi, Utah. In 2024, the company recognized a $588 million cash benefit from the CHIPS Act Investment Tax Credit.